Merger Roundup: August 26, 2013 - Presented by: The Aol. On Network

Amgen (AMGN) and Onyx Pharmaceuticals (ONXX) announced they have approved a transaction under which Amgen will acquire all of the outstanding shares of Onyx for $125 per share in cash. The purchase price is $10.4 billion, or $9.7 billion net of estimated Onyx cash.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
FTR $ 6.785 0.85 ▲ 14.23%
T $ 36.97 1.32 ▲ 3.70%
WIN $ 12.86 2.33 ▲ 22.13%
CTL $ 41.09 3.38 ▲ 8.96%
RAD $ 6.515 0.18 ▼ 2.62%
SIRI $ 3.47 0.09 ▲ 2.66%
AAPL $ 98.84 0.18 ▼ 0.18%
VZ $ 52.43 0.85 ▲ 1.65%

As of 7/29/2014, 09:55 AM
More Most Active